Header Logo

Revathy Nadhan

TitleScholar,Assoc Research
InstitutionUniversity of Oklahoma Health Sciences Center
DepartmentStephenson Cancer Center
AddressBRC 1417
975 NE 10th St
Oklahoma City OK 73104
Phone405/271-8001 ext 18001
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Nadhan R, Kashyap S, Ha JH, Jayaraman M, Song YS, Isidoro C, Dhanasekaran DN. Targeting Oncometabolites in Peritoneal Cancers: Preclinical Insights and Therapeutic Strategies. Metabolites. 2023 Apr 30; 13(5). PMID: 37233659; PMCID: PMC10222714.
      Citations: 1     
    2. Nadhan R, Isidoro C, Song YS, Dhanasekaran DN. Signaling by LncRNAs: Structure, Cellular Homeostasis, and Disease Pathology. Cells. 2022 08 13; 11(16). PMID: 36010595; PMCID: PMC9406440.
      Citations: 2     Fields:    Translation:Cells
    3. Rajan A, Varghese GR, Yadev I, Anandan J, Latha NR, Patra D, Krishnan N, Kuppusamy K, Warrier AV, Bhushan S, Nadhan R, Ram Kumar RM, Srinivas P. Modulation of BRCA1 mediated DNA damage repair by deregulated ER-a signaling in breast cancers. Am J Cancer Res. 2022; 12(1):17-47. PMID: 35141003.
      Citations: 2     
    4. Ha JH, Jayaraman M, Nadhan R, Kashyap S, Mukherjee P, Isidoro C, Song YS, Dhanasekaran DN. Unraveling Autocrine Signaling Pathways through Metabolic Fingerprinting in Serous Ovarian Cancer Cells. Biomedicines. 2021 Dec 16; 9(12). PMID: 34944743.
      Citations: 6     
    5. Rajan A, Nadhan R, Latha NR, Krishnan N, Warrier AV, Srinivas P. Deregulated estrogen receptor signaling and DNA damage response in breast tumorigenesis. Biochim Biophys Acta Rev Cancer. 2021 01; 1875(1):188482. PMID: 33260050.
      Citations: 4     Fields:    Translation:HumansCells
    6. Nadhan R, Patra D, Krishnan N, Rajan A, Gopala S, Ravi D, Srinivas P. Perspectives on mechanistic implications of ROS inducers for targeting viral infections. Eur J Pharmacol. 2021 Jan 05; 890:173621. PMID: 33068588.
      Citations: 4     Fields:    Translation:HumansAnimalsCellsPHPublic Health
    7. Nadhan R, Vaman JV, Sengodan SK, Hemalatha SK, Chellappan N, Sadasivan S, Pasuthottiyil Varkey A, Yesodharan S, Raji Sathyanpillai K, Bhuvaneswari Venugopal AK, Prameelakumari Sreenivasan S, Rajan A, Latha NR, Varghese GR, Thankappan R, Achyutuni S, Sreekumar Usha JD, Vijayamma Anilkumar T, Srinivas P. BRCA1 promoter hypermethylation in human placenta: a hidden link with ß-hCG expression. Carcinogenesis. 2020 07 10; 41(5):611-624. PMID: 31219560.
      Citations: 1     Fields:    Translation:HumansCells
    8. Nadhan R, Srinivas P, Pillai MR. RTKs in pathobiology of head and neck cancers. Adv Cancer Res. 2020; 147:319-373. PMID: 32593405.
      Citations: 4     Fields:    Translation:HumansAnimalsCells
    9. Latha NR, Rajan A, Nadhan R, Achyutuni S, Sengodan SK, Hemalatha SK, Varghese GR, Thankappan R, Krishnan N, Patra D, Warrier A, Srinivas P. Gene expression signatures: A tool for analysis of breast cancer prognosis and therapy. Crit Rev Oncol Hematol. 2020 Jul; 151:102964. PMID: 32464482.
      Citations: 11     Fields:    Translation:HumansCells
    10. Sengodan SK, Hemalatha SK, Nadhan R, Somanathan T, Mathew AP, Chil A, Kopczynski J, Nair RS, Kumar JM, Srinivas P. ß-hCG-induced mutant BRCA1 ignites drug resistance in susceptible breast tissue. Carcinogenesis. 2019 Nov 25; 40(11):1415-1426. PMID: 30963174.
      Citations: 4     Fields:    Translation:HumansAnimalsCells
    11. Kuppusamy K, Rajan A, Warrier A, Nadhan R, Patra D, Srinivas P. Cytological Grading of Breast Tumors-The Human and Canine Perspective. Front Vet Sci. 2019; 6:283. PMID: 31508437.
      Citations: 2     
    12. Hemalatha SK, Sengodan SK, Nadhan R, Dev J, Sushama RR, Somasundaram V, Thankappan R, Rajan A, Latha NR, Varghese GR, Mathew AP, Somanathan T, Srinivas P. Brcal Defective Breast Cancer Cells Induce in vitro Transformation of Cancer Associated Fibroblasts (CAFs) to Metastasis Associated Fibroblasts (MAF). Sci Rep. 2018 09 17; 8(1):13903. PMID: 30224826.
      Citations: 8     Fields:    Translation:HumansCells
    13. Sengodan SK, K H S, Nadhan R, Srinivas P. Regulation of epithelial to mesenchymal transition by BRCA1 in breast cancer. Crit Rev Oncol Hematol. 2018 Mar; 123:74-82. PMID: 29482782.
      Citations: 10     Fields:    Translation:HumansCells
    14. Achyutuni S, Nadhan R, Sengodan SK, Srinivas P. The prodigious network of chromosome 17 miRNAs regulating cancer genes that influence the hallmarks of cancer. Semin Oncol. 2017 08; 44(4):254-264. PMID: 29526253.
      Citations: 2     Fields:    Translation:HumansCells
    15. Sengodan SK, Rajan A, Hemalatha SK, Nadhan R, Jaleel A, Srinivas P. Proteomic Profiling of ß-hCG-Induced Spheres in BRCA1 Defective Triple Negative Breast Cancer Cells. J Proteome Res. 2018 01 05; 17(1):276-289. PMID: 29028349.
      Citations: 4     Fields:    Translation:HumansCells
    16. Sengodan SK, Nadhan R, Nair RS, Hemalatha SK, Somasundaram V, Sushama RR, Rajan A, Latha NR, Varghese GR, Thankappan RK, Kumar JM, Chil A, Anilkumar TV, Srinivas P. BRCA1 regulation on ß-hCG: a mechanism for tumorigenicity in BRCA1 defective breast cancer. Oncogenesis. 2017 Sep 04; 6(9):e376. PMID: 28869585.
      Citations: 8     
    17. Nadhan R, Vaman JV, C N, Kumar Sengodan S, Krishnakumar Hemalatha S, Rajan A, Varghese GR, Rl N, Bv AK, Thankappan R, Srinivas P. Insights into dovetailing GTD and Cancers. Crit Rev Oncol Hematol. 2017 Jun; 114:77-90. PMID: 28477749.
      Citations: 10     Fields:    Translation:Humans
    18. Nair RS, Kumar JM, Jose J, Somasundaram V, Hemalatha SK, Sengodan SK, Nadhan R, Anilkumar TV, Srinivas P. Increased sensitivity of BRCA defective triple negative breast tumors to plumbagin through induction of DNA Double Strand Breaks (DSB). Sci Rep. 2016 05 25; 6:26631. PMID: 27220670.
      Citations: 7     Fields:    Translation:HumansAnimalsCells
    19. Somasundaram V, Nadhan R, K Hemalatha S, Kumar Sengodan S, Srinivas P. Nitric oxide and reactive oxygen species: Clues to target oxidative damage repair defective breast cancers. Crit Rev Oncol Hematol. 2016 May; 101:184-92. PMID: 27017408.
      Citations: 7     Fields:    Translation:HumansCells
    20. Reshma RS, Sreelatha KH, Somasundaram V, Satheesh Kumar S, Nadhan R, Nair RS, Srinivas P. Plumbagin, a naphthaquinone derivative induces apoptosis in BRCA 1/2 defective castrate resistant prostate cancer cells as well as prostate cancer stem-like cells. Pharmacol Res. 2016 Mar; 105:134-45. PMID: 26808083.
      Citations: 8     Fields:    Translation:HumansCells
    Nadhan's Networks
    Click the
    buttons for more information and interactive visualizations!
    Concepts (82)
    Co-Authors (4)
    Similar People (60)
    Same Department Expand Description